Escherichia coli (commonly abbreviated as E. coli) is a Gram-negative, facultative anaerobic bacterium that is commonly found in the lower intestine of warm-blooded organisms . E. coli strains are diverse, with some being harmless commensals and others being pathogenic, causing diseases like diarrhea, urinary tract infections, and more serious conditions .
Recombinant Escherichia coli O139:H28 Protein CrcB homolog (CrcB) is a protein produced using recombinant DNA technology . Specifically, the CrcB homolog (crcB) is derived from the E. coli O139:H28 strain, with the "recombinant" aspect indicating that the gene encoding this protein has been cloned and expressed in a host organism, often to produce large quantities of the protein for research or other applications .
The CrcB homolog is related to fluoride-specific ion channel protein FluC . Overexpression of CrcB leads to various effects, including camphor resistance, chromosome condensation, and suppression of growth defects in certain mutants .
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Tag type is determined during production. If you require a specific tag, please inform us for preferential development.
Crucial for reducing intracellular fluoride concentration and mitigating its toxicity.
KEGG: ecw:EcE24377A_0649
The CrcB homolog in E. coli O139:H28 functions primarily as a fluoride ion channel protein involved in fluoride resistance mechanisms. Unlike colonization factors such as the coli surface-associated antigen 1 (CS1) which are often plasmid-encoded in this serotype, CrcB is typically chromosomally encoded and contributes to bacterial survival in environments containing fluoride ions. The protein forms part of a protective mechanism that prevents fluoride toxicity by exporting fluoride ions from the bacterial cytoplasm, thus maintaining intracellular homeostasis.
When designing experiments to investigate CrcB function, researchers should consider comparative analyses with related homologs in other bacterial species and use genetic complementation studies to validate function. Expression studies should incorporate both chromosomal and plasmid-based systems, as plasmid-encoded elements in E. coli O139:H28 may exhibit regulatory interactions with chromosomal genes .
Expression of recombinant CrcB homolog requires careful optimization of expression systems. Based on methodology principles from similar bacterial membrane proteins, the following protocol is recommended:
Vector selection: Use pET-based expression vectors for high-yield expression or pBAD vectors for more controlled expression under the arabinose promoter.
Host strain selection: Transform into E. coli BL21(DE3) for high expression yields or into a derivative of strain E24377 without large plasmids to study native regulatory interactions .
Expression conditions:
Grow cultures at 30°C rather than 37°C to reduce inclusion body formation
Induce with 0.5 mM IPTG (for T7-based systems) or 0.2% arabinose (for pBAD systems)
Express at 18°C post-induction for 16-20 hours for optimal folding
Regulatory considerations: If expression is low or absent, co-transform with a plasmid carrying regulatory elements such as those homologous to the cfaD/rns regulatory system, which has been shown to regulate expression of surface proteins in E. coli O139:H28 .
Verification: Confirm expression using Western blotting with anti-His tag antibodies (if using His-tagged constructs) and assess membrane localization using fractionation techniques.
To verify the fluoride resistance function of recombinant CrcB, a systematic experimental approach should be implemented:
Growth inhibition assays: Compare growth curves of wild-type, crcB knockout, and crcB-complemented strains in media containing various concentrations of NaF (0-50 mM). Record OD600 measurements at regular intervals (0, 2, 4, 8, 12, 24 hours) .
Fluoride uptake measurements: Use fluoride-specific electrodes to measure intracellular vs. extracellular fluoride concentrations.
Control variables: Maintain consistent pH (7.2-7.4), temperature (37°C), media composition, inoculum density, and growth phase across all experimental conditions .
Data collection design: Implement a data table format as follows:
| Strain Type | NaF Concentration (mM) | OD600 (0h) | OD600 (4h) | OD600 (8h) | OD600 (12h) | OD600 (24h) |
|---|---|---|---|---|---|---|
| WT O139:H28 | 0 | 0.05 | 0.32 | 0.78 | 1.45 | 1.89 |
| WT O139:H28 | 10 | 0.05 | 0.29 | 0.65 | 1.32 | 1.76 |
| ΔcrcB | 0 | 0.05 | 0.31 | 0.76 | 1.42 | 1.87 |
| ΔcrcB | 10 | 0.05 | 0.18 | 0.31 | 0.45 | 0.62 |
| ΔcrcB+pCrcB | 0 | 0.05 | 0.30 | 0.74 | 1.40 | 1.85 |
| ΔcrcB+pCrcB | 10 | 0.05 | 0.28 | 0.63 | 1.28 | 1.73 |
Statistical analysis: Apply two-way ANOVA to analyze the interaction between strain type and fluoride concentration, followed by post-hoc tests to identify significant differences between conditions .
A comprehensive experimental workflow for CrcB characterization should include:
Gene amplification and cloning:
Design primers with appropriate restriction sites
PCR amplify the crcB gene from E. coli O139:H28 genomic DNA
Clone into expression vectors with affinity tags (His6 or FLAG)
Expression optimization:
Test multiple expression conditions (temperature, induction time, inducer concentration)
Compare membrane vs. soluble fractions to confirm localization
Protein purification:
Solubilize membranes using mild detergents (DDM, LDAO)
Perform affinity chromatography
Further purify by size exclusion chromatography
Functional characterization:
Reconstitute protein in liposomes
Perform fluoride transport assays
Assess channel conductance using electrophysiology
Structural analysis:
Analyze secondary structure using circular dichroism
Attempt crystallization for X-ray crystallography or prepare for cryo-EM
The experimental design should include appropriate controls at each stage and follow a systematic methodology with a clear rationale for each step . Transformants carrying only structural genes for CrcB may not express the protein, so co-expression with identified regulatory elements should be considered based on the regulatory patterns observed with other surface proteins in E. coli O139:H28 .
When investigating CrcB regulation, control the following variables:
Plasmid factors:
Growth conditions:
Culture medium composition (especially ion content)
Growth phase (log vs. stationary)
Temperature and pH
Aeration conditions
Host strain characteristics:
Presence of competing regulatory networks
Background expression of related transporters
Strain-specific genetic factors that might influence membrane protein expression
Data collection methodology:
Use RT-qPCR for transcript analysis
Western blotting for protein quantification
Fluorescence microscopy for localization studies
Flow cytometry for population-level expression analysis
Experimental controls:
This approach allows for systematic isolation of variables affecting CrcB expression, following principles of good research methodology design .
To investigate protein-protein interactions involving CrcB:
In vivo approaches:
Bacterial two-hybrid system (BACTH) specifically designed for membrane proteins
Fluorescence resonance energy transfer (FRET) using fluorescently tagged proteins
Co-immunoprecipitation with membrane-compatible detergents
In vitro approaches:
Pull-down assays using purified components
Surface plasmon resonance (SPR)
Native PAGE analysis of membrane extracts
Genetic approaches:
Synthetic lethality screening
Suppressor mutation analysis
Phenotypic analysis of double knockout strains
Data recording and analysis:
Experimental design considerations:
When facing contradictory results in CrcB functional studies:
For example, if fluoride resistance assays show conflicting results, systematically evaluate media composition, growth conditions, and exact genetic backgrounds of the strains used. Document all variables in a comprehensive table to identify potential sources of variation.
When analyzing CrcB expression data:
Example data presentation format:
| Condition | Relative CrcB Expression (Mean ± SEM) | n | Statistical Significance |
|---|---|---|---|
| Control | 1.00 ± 0.08 | 6 | Reference |
| 5 mM NaF | 2.34 ± 0.21 | 6 | p < 0.01 |
| 10 mM NaF | 3.87 ± 0.31 | 6 | p < 0.001 |
| pH 6.0 | 1.56 ± 0.17 | 6 | p < 0.05 |
| pH 8.0 | 0.78 ± 0.09 | 6 | p > 0.05 |
For effective documentation and presentation of CrcB localization data:
Standardized imaging protocols:
Establish consistent microscopy settings (exposure, gain, resolution)
Use appropriate controls for autofluorescence and background
Include scale bars and time stamps on all images
Quantitative image analysis:
Measure fluorescence intensity across cellular compartments
Track protein movement in time-lapse studies
Calculate co-localization coefficients with marker proteins
Data organization frameworks:
Create multi-panel figures showing representative images alongside quantification
Develop heatmaps showing localization patterns across conditions
Use line scan analysis to demonstrate membrane vs. cytoplasmic distribution
Statistical representation:
Dynamic data presentation:
For trafficking studies, create kymographs showing protein movement over time
Present fluorescence recovery after photobleaching (FRAP) data as recovery curves
Develop 3D reconstructions for complex subcellular localization patterns
Example data table format:
| Condition | Membrane Localization (%) | Cytoplasmic Localization (%) | Polar Foci (%) | n (cells) |
|---|---|---|---|---|
| WT | 78.3 ± 5.2 | 18.4 ± 3.7 | 3.3 ± 1.1 | 245 |
| ΔflhC | 65.1 ± 6.3 | 29.8 ± 4.2 | 5.1 ± 1.9 | 231 |
| ΔcheY | 81.2 ± 4.8 | 15.3 ± 3.5 | 3.5 ± 1.3 | 253 |
| 10mM NaF | 89.7 ± 3.6 | 8.9 ± 2.1 | 1.4 ± 0.8 | 238 |
Advanced methodological approaches for studying CrcB structural dynamics include:
Single-molecule techniques:
Single-molecule FRET to measure conformational changes
Atomic force microscopy (AFM) to probe membrane protein topology
Single-channel electrophysiology to monitor gating events
Computational approaches:
Molecular dynamics simulations of CrcB in membrane environments
Homology modeling based on related channel structures
In silico docking studies with fluoride and potential inhibitors
Spectroscopic methods:
Site-directed spin labeling combined with electron paramagnetic resonance (EPR)
Hydrogen/deuterium exchange mass spectrometry
Solid-state NMR of reconstituted CrcB in nanodiscs
Structural biology integration:
Design truncation constructs to facilitate crystallization
Engineer stabilizing mutations based on computational predictions
Use lipidic cubic phase crystallization for membrane proteins
Functional correlation studies:
Correlate structural data with transport measurements
Combine electrophysiology with simultaneous fluorescence imaging
Implement cysteine accessibility methods to probe channel gating
When designing these experiments, researchers should carefully control for the effects of tags, fluorophores, or mutations on protein function. Verification of channel activity should be performed in parallel with structural studies to ensure physiological relevance .
Optimizing CRISPR-Cas9 genome editing for CrcB studies:
Guide RNA design considerations:
Select target sites with minimal off-target potential
Validate guide RNA efficiency in silico before implementation
Design multiple guide RNAs targeting different regions of crcB
Delivery optimization:
Use temperature-sensitive plasmids for transient Cas9 expression
Optimize electroporation parameters specifically for E. coli O139:H28
Consider lambda Red recombination system co-expression for improved efficiency
Editing strategies:
For knockout studies: design repair templates with selectable markers
For point mutations: include silent mutations in PAM sites to prevent re-cutting
For tagging: ensure tag insertion maintains protein functionality
Screening methodology:
Develop PCR-based screening protocols for identifying successful edits
Implement fluoride sensitivity assays for functional validation
Use sequencing to confirm precise edits and rule out off-target effects
Controls and validation:
Create parallel edits in reference E. coli strains for comparison
Complement edited strains to confirm phenotype specificity
Verify expression levels of nearby genes to rule out polar effects
Table of recommended parameters for CRISPR-Cas9 editing in E. coli O139:H28:
| Parameter | Recommended Setting | Notes |
|---|---|---|
| Guide RNA length | 20 nucleotides | Avoid homopolymer stretches |
| PAM site | NGG | Standard S. pyogenes Cas9 |
| Cas9 expression | Inducible | 0.2% arabinose for 2-3 hours |
| Homology arm length | 500-700 bp | For precise edits |
| Selection marker | Kanamycin resistance | For knockout constructs |
| Recovery medium | SOC with 0.2% glucose | For 2 hours post-transformation |
| Verification method | Sanger sequencing | Of entire targeted region |
To explore novel CrcB functions beyond fluoride transport:
Transcriptomic approaches:
RNA-seq under diverse stress conditions
Differential expression analysis comparing wild-type and ΔcrcB strains
Co-expression network analysis to identify functional associations
Interactome mapping:
Proximity labeling methods (BioID or APEX2)
Crosslinking mass spectrometry
Membrane-specific yeast two-hybrid screening
Phenotypic profiling:
High-throughput phenotype microarrays
Biofilm formation assays under various conditions
Host cell adhesion and invasion studies
Metabolomic investigations:
Targeted metabolite analysis in WT vs. ΔcrcB strains
Isotope labeling to track metabolic flux changes
Lipidomic analysis to assess membrane composition alterations
In vivo significance studies:
Animal infection models comparing WT and ΔcrcB strains
Competitive index assays in mixed infections
Tissue-specific bacterial gene expression analysis
These approaches should be integrated with plasmid transformation and regulatory studies, particularly considering the regulatory elements identified in E. coli O139:H28 that control surface protein expression . Researchers should apply multi-locus sequence typing (MLST) methods to position their O139:H28 strain within the broader E. coli phylogeny, which can provide context for interpreting CrcB function in relation to pathogenicity .
Common challenges in CrcB purification and their solutions:
Low expression levels:
Protein instability:
Add stabilizing ligands during purification
Screen different detergents (DDM, LMNG, GDN)
Reduce purification temperature to 4°C throughout
Include protease inhibitor cocktails
Aggregation issues:
Optimize detergent:protein ratio
Include glycerol (10-20%) in all buffers
Apply on-column folding strategies
Consider fusion partners that enhance solubility
Contaminating proteins:
Implement multi-step purification (IMAC followed by SEC)
Use more stringent washing conditions during affinity steps
Consider on-column detergent exchange
Apply ion exchange as an additional purification step
Functional assessment challenges:
Develop robust proteoliposome reconstitution protocols
Standardize fluoride detection methods
Include positive controls (known fluoride transporters)
Validate protein folding using circular dichroism
Quality control checkpoints table:
| Purification Stage | Quality Control Test | Acceptance Criteria | Troubleshooting |
|---|---|---|---|
| Crude extract | Western blot | Detectable band at ~11-12 kDa | Adjust induction conditions |
| Membrane fraction | SDS-PAGE | Enrichment of target band | Optimize membrane preparation |
| IMAC eluate | SDS-PAGE | >60% purity | Increase imidazole in wash buffer |
| SEC fraction | SDS-PAGE | >90% purity | Apply additional purification step |
| Final product | Circular dichroism | α-helical spectrum | Optimize detergent composition |
| Reconstituted protein | Fluoride transport | >2-fold over protein-free liposomes | Adjust protein:lipid ratio |
Emerging technologies with potential for CrcB research:
Cryo-electron tomography:
Visualize CrcB in its native membrane environment
Study channel arrangement and clustering
Examine structural changes under different ion concentrations
Single-cell technologies:
Single-cell RNA-seq to identify cell-to-cell variation in crcB expression
Microfluidics-based single-cell phenotyping
Time-lapse fluorescence microscopy with microfluidic devices
Nanopore sequencing applications:
Direct RNA sequencing to identify transcription start sites
Epigenetic modifications affecting crcB expression
Long-read sequencing for genomic context analysis
Advanced mass spectrometry:
Targeted proteomics to quantify low-abundance CrcB
Crosslinking MS for in vivo interaction mapping
Native MS to study intact membrane protein complexes
Synthetic biology approaches:
CrcB-based biosensors for fluoride detection
Minimal synthetic cells with engineered fluoride transport
Orthogonal expression systems for controlled CrcB studies
These technologies can be integrated with established approaches for studying plasmid-encoded gene regulation in E. coli O139:H28, potentially revealing interactions between chromosomal CrcB and plasmid-encoded functions .
Systems biology approaches for contextualizing CrcB function:
Multi-omics integration:
Combine transcriptomics, proteomics, and metabolomics data
Develop network models of CrcB-associated pathways
Identify condition-specific regulatory networks
Genome-scale modeling:
Incorporate CrcB function into constraint-based metabolic models
Simulate effects of crcB deletion on cellular physiology
Predict condition-specific phenotypes
Network analysis methods:
Construct protein-protein interaction networks
Identify functional modules associated with CrcB
Apply graph theory to predict critical nodes
Comparative genomics frameworks:
Analyze CrcB conservation across pathogenic E. coli strains
Compare genomic context of crcB across different serotypes
Identify serotype-specific regulatory elements
Integration with virulence mechanisms:
Correlate CrcB activity with virulence factor expression
Assess the impact of environmental signals on both systems
Develop multi-scale models spanning molecular to host-pathogen interactions
These approaches should consider the serotype-specific characteristics of E. coli O139:H28, including its plasmid-encoded virulence factors and regulatory systems, which may interact with CrcB function .